Marcelo Rugiero Selected Research

Alkaline Phosphatase

12/2022

[Clinical Practice Guidelines for diagnosis of organic involvement of amyloidosis: Part 3/3 Year 2020]

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcelo Rugiero Research Topics

Disease

2	Amyloidosis 12/2022 - 12/2021
2	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 01/2022 - 01/2016
1	Guillain-Barre Syndrome 09/2023
1	Facial Paralysis (Facial Palsy) 09/2023
1	Paresthesia (Dysesthesia) 09/2023
1	Multiple Sclerosis 07/2023
1	Relapsing-Remitting Multiple Sclerosis 07/2023
1	Central Nervous System Vasculitis 07/2023
1	COVID-19 03/2022
1	Sleep Wake Disorders 03/2022
1	Chronobiology Disorders (Circadian Rhythm Disorder) 03/2022
1	Infections 03/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2022
1	REM Sleep Behavior Disorder 03/2022
1	Glycogen Storage Disease Type II (Pompe's Disease) 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2016

Drug/Important Bio-Agent (IBA)

1	COVID-19 VaccinesIBA 09/2023
1	Alemtuzumab (Campath)FDA Link 07/2023
1	Alkaline PhosphataseIBA 12/2022
1	CreatinineIBA 12/2022
1	MelatoninIBA 03/2022
1	InotersenIBA 01/2022
1	tafamidisIBA 01/2022
1	Diflunisal (Dolobid)FDA Link 01/2022
1	Congo RedIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	EnzymesIBA 01/2018
1	alpha-Glucosidases (Acid Maltase)IBA 01/2018
1	AcidsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 05/2017
1	Prealbumin (Transthyretin)IBA 01/2016

Therapy/Procedure

1	Length of Stay 09/2023
1	Therapeutics 07/2023